The 29th edition summarizes some of the latest research from CHÉOS Scientists, including patient preferences for rheumatoid arthritis prevention, a kidney disease risk-prediction tool, and sleep disturbance in adolescents.
Read More
Canada is the first country to approve the pain drug for severe opioid use disorder, a result of research led by CHÉOS and PHC scientists and staff.
Read More
A $2.5 million project called ‘PRECISION’ is underway. It will study more than a million Canadians with inflammatory diseases of the skin, joint or bowel
Read More
PORTIA is the latest study in a long-term program of research that is developing evidence-based overdose prevention strategies and helping address the opioid crisis
Read More
For National Health Ethics Week, read about our newest Scientist, Dr. Anita Ho, and the unique approach she is taking to promoting ethical decision-making
Read More
The 27th edition summarizes some of the latest research from CHÉOS Scientists, including incarceration and homelessness, adverse events, and societal values related to drug funding.
Read More
CHÉOS Scientists are leading three of the projects funded through this round of the competition and a further seven projects are supported by CHÉOS Scientists as co-investigators.
Read More
The 25th instalment features some of the latest research from CHÉOS Scientists, featuring Drs. Geller, Bansback, Harrison, Lynd, and Anis.
Read More
CHÉOS Scientists lead a number of Methods Clusters and projects with the BC SUPPORT Unit.
Read More
Reach out With Arthritis 2018 features six speakers, two of whom are CHÉOS Scientists
Read More